Association between variations in coagulation system genes and carotid plaque
David Della-Morte1, Ashley Beecham, Chuanhui Dong
1Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL, USA.
Journal of the Neurological Sciences
|September 18, 2012
Summary
Genetic variations in von Willebrand factor (vWF), THBS1, and SERPINE1 genes are linked to subclinical atherosclerosis, specifically carotid plaque development and characteristics.
Area of Science:
- Cardiovascular Genetics
- Atherosclerosis Research
- Molecular Biology
Background:
- Genetic variations in coagulation and fibrinolysis influence atherosclerosis risk.
- Limited data exists on the association between subclinical atherosclerosis and coagulation system genes.
- Subclinical atherosclerosis is a precursor to stroke and cardiovascular disease.
Purpose of the Study:
- To investigate the association between single nucleotide polymorphisms (SNPs) in coagulation system genes and subclinical carotid plaque phenotypes.
- To explore gene-gene interactions and haplotypes within coagulation pathways.
- To validate findings in an independent cohort.
Main Methods:
- Utilized high-resolution B-mode carotid ultrasound to assess carotid plaque in 287 Dominicans.
- Analyzed 101 SNPs across 23 coagulation genes using logistic regression, controlling for cardiovascular risk factors.
- Conducted haplotype and gene-interaction analyses, followed by replication in 301 individuals.
Main Results:
- Identified significant associations between vWF and THBS1 genes and carotid plaque size and surface irregularity (p ≤ 0.01).
- Replication analysis confirmed associations for 5 SNPs in the vWF gene with plaque size (p ≤ 0.05).
- SERPINE1 gene emerged as significant in haplotype and interaction analyses.
Conclusions:
- Genetic variations in vWF, THBS1, and SERPINE1 play a role in the development of atherosclerotic plaque.
- These findings highlight specific coagulation genes as potential targets for understanding atherosclerosis.
- Further research can explore the functional mechanisms linking these genes to plaque formation.
Related Concept Videos
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

